CoChat
Sign Up
Cited by 304

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Alternatively activated macrophages in helminth infections

Kreider, Timothy, Anthony, Robert M., Urban, Joseph F., Gause, William C.·2007·Current Opinion in Immunology
DOI 10.1016/j.coi.2007.07.002
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.coi.2007.07.002

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 43

  1. Tato, 2006, Helper T cell differentiation enters a new era: le roi est mort; vive le roi!, J Exp Med, 203, 809, 10.1084/jem.20060522 · DOI
  2. Herbert, 2004, Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology, Immunity, 20, 623, 10.1016/S1074-7613(04)00107-4 · DOI
  3. Reece, 2006, Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophages, Infect Immun, 74, 4970, 10.1128/IAI.00687-06 · DOI
  4. Rodriguez-Sosa, 2002, Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability, Infect Immun, 70, 3656, 10.1128/IAI.70.7.3656-3664.2002 · DOI
  5. Dzik, 2004, A non-classical type of alveolar macrophage response to Trichinella spiralis infection, Parasite Immunol, 26, 197, 10.1111/j.0141-9838.2004.00700.x · DOI
  6. Donnelly, 2005, Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages, Infect Immun, 73, 166, 10.1128/IAI.73.1.166-173.2005 · DOI
  7. Oshiro, 2005, Anti-inflammatory activity of PAS-1, a protein component of Ascaris suum, Inflamm Res, 54, 17, 10.1007/s00011-004-1316-7 · DOI
  8. Nair, 2003, Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro, Immunol Lett, 85, 173, 10.1016/S0165-2478(02)00225-0 · DOI
  9. Nair, 2005, Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells, Infect Immun, 73, 385, 10.1128/IAI.73.1.385-394.2005 · DOI
  10. Raes, 2002, Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages, J Leukoc Biol, 71, 597, 10.1189/jlb.71.4.597 · DOI
  11. Raes, 2005, Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation, J Leukoc Biol, 77, 321, 10.1189/jlb.0304212 · DOI · Paper page
  12. Ruckerl, 2006, Alternatively activated macrophages express the IL-27 receptor alpha chain WSX-1, Immunobiology, 211, 427, 10.1016/j.imbio.2006.05.008 · DOI
  13. Gratchev, 2005, Interleukin-4 and dexamethasone counter-regulate extracellular matrix remodelling and phagocytosis in type-2 macrophages, Scand J Immunol, 61, 10, 10.1111/j.0300-9475.2005.01524.x · DOI
  14. Stumpo, 2003, IL-10 induces gene expression in macrophages: partial overlap with IL-5 but not with IL-4 induced genes, Cytokine, 24, 46, 10.1016/S1043-4666(03)00270-9 · DOI
  15. Atochina, 2001, A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism, J Immunol, 167, 4293, 10.4049/jimmunol.167.8.4293 · DOI
  16. Brys, 2005, Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection, J Immunol, 174, 6095, 10.4049/jimmunol.174.10.6095 · DOI
  17. Pesce, 2006, The IL-21 receptor augments Th2 effector function and alternative macrophage activation, J Clin Invest, 116, 2044, 10.1172/JCI27727 · DOI
  18. Frohlich, 2007, IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo, Blood, 109, 2023, 10.1182/blood-2006-05-021600 · DOI
  19. Omori, 2007, Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin, J Immunol, 178, 1396, 10.4049/jimmunol.178.3.1396 · DOI
  20. Taylor, 2006, F4/80+ alternatively activated macrophages control CD4+ T cell hyporesponsiveness at sites peripheral to filarial infection, J Immunol, 176, 6918, 10.4049/jimmunol.176.11.6918 · DOI
  21. Rodriguez-Sosa, 2006, Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages, Cell Immunol, 242, 61, 10.1016/j.cellimm.2006.09.006 · DOI
  22. Reese, 2007, Chitin induces accumulation in tissue of innate immune cells associated with allergy, Nature, 10.1038/nature05746 · DOI
  23. Hesse, 2001, Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of l-arginine metabolism, J Immunol, 167, 6533, 10.4049/jimmunol.167.11.6533 · DOI
  24. Hesse, 2000, NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease, Am J Pathol, 157, 945, 10.1016/S0002-9440(10)64607-X · DOI
  25. Hayashi, 1999, Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens, J Immunol, 163, 6702, 10.4049/jimmunol.163.12.6702 · DOI
  26. Mantovani, 2002, Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes, Trends Immunol, 23, 549, 10.1016/S1471-4906(02)02302-5 · DOI · Paper page
  27. Liu, 2004, Requirements for the development of IL-4-producing T cells during intestinal nematode infections: what it takes to make a Th2 cell in vivo, Immunol Rev, 201, 57, 10.1111/j.0105-2896.2004.00186.x · DOI
  28. Barner, 1998, Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses, Curr Biol, 8, 669, 10.1016/S0960-9822(98)70256-8 · DOI
  29. Urban, 2000, IL-13-mediated worm expulsion is B7 independent and IFN-gamma sensitive, J Immunol, 164, 4250, 10.4049/jimmunol.164.8.4250 · DOI
  30. Rutitzky, 2003, Disruption of the ICOS-B7RP-1 costimulatory pathway leads to enhanced hepatic immunopathology and increased gamma interferon production by CD4 T cells in murine schistosomiasis, Infect Immun, 71, 4040, 10.1128/IAI.71.7.4040-4044.2003 · DOI
  31. Greenwald, 1997, Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response, J Immunol, 158, 4088, 10.4049/jimmunol.158.9.4088 · DOI
  32. Greenwald, 2001, CTLA-4 regulates induction of anergy in vivo, Immunity, 14, 145, 10.1016/S1074-7613(01)00097-8 · DOI · Paper page
  33. Liang, 2003, Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses, Eur J Immunol, 33, 2706, 10.1002/eji.200324228 · DOI
  34. Smith, 2004, Schistosoma mansoni worms induce anergy of T cells via selective upregulation of programmed death ligand 1 on macrophages, J Immunol, 173, 1240, 10.4049/jimmunol.173.2.1240 · DOI
  35. Terrazas, 2005, Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis, Int J Parasitol, 35, 1349, 10.1016/j.ijpara.2005.06.003 · DOI
  36. Sandler, 2003, Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair, J Immunol, 171, 3655, 10.4049/jimmunol.171.7.3655 · DOI
  37. Liu, 2004, FIZZ1 stimulation of myofibroblast differentiation, Am J Pathol, 164, 1315, 10.1016/S0002-9440(10)63218-X · DOI
  38. Gratchev, 2001, Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3, Scand J Immunol, 53, 386, 10.1046/j.1365-3083.2001.00885.x · DOI · Paper page
  39. Gause, 2003, The immune response to parasitic helminths: insights from murine models, Trends Immunol, 24, 269, 10.1016/S1471-4906(03)00101-7 · DOI
  40. Finkelman, 2004, Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites, Immunol Rev, 201, 139, 10.1111/j.0105-2896.2004.00192.x · DOI · Paper page
  41. Voehringer, 2007, Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages, J Leukoc Biol, 10.1189/jlb.1106686 · DOI · Paper page
  42. Owhashi, 2000, Identification of a novel eosinophil chemotactic cytokine (ECF-L) as a chitinase family protein, J Biol Chem, 275, 1279, 10.1074/jbc.275.2.1279 · DOI
  43. Zhu, 2004, Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation, Science, 304, 1678, 10.1126/science.1095336 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kreider, T., Anthony, R. M., Urban, J. F., & Gause, W. C.
Venue
Current Opinion in Immunology
Publisher
Elsevier BV
Published
2007-08
Volume
19
Issue
4
Pages
448-453
ISSN
0952-7915
DOI
10.1016/j.coi.2007.07.002
Cited by
304
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review